TTRX - Turn Therapeutics Inc.
3.35
-0.030 -0.896%
Share volume: 25,791
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$3.38
-0.03
-0.01%
View ratios
| Fiscal Date | 09-30-2025 | |
|---|---|---|
| Fiscal Quarter | Q3 2025 | |
| Report Date | 11-13-2025 | |
| Total revenue | 0.000 | |
| Cost of revenue | 0.000 | |
| Gross profit | 0.000 | |
| Operating expenses | 1.914 M | |
| Selling general and admin | 1.755 M | |
| Research and development | 158.699 K | |
| Total expenses | 1.914 M | |
| Operating income | -1.914 M | |
| Ebit | -1.909 M | |
| Pretax income | -1.904 M | |
| Income tax | 0.000 | |
| Net income basic | 0.000 | |
| Net income | -1.904 M | |